Hydroxyl and carbonate radicals Hydroxyl radical is one of the most reactive radicals occurring in biological systems and causes damage to all important biomolecules involving DNA, proteins, and membranes (Valko et al
Participation depends on provider review and medical appropriateness
According to standards set by the U.S
Its clinical development for obesity was discontinued in 2007 after the pivotal 536-participant Phase IIb trial failed to meet its primary efficacy endpoint, and no formulation of the compound has received FDA approval since
Martin KA, Anderson RR, Chang RJ, et al
It directs anyone who sees those changes, or who holds a preparation past its date, to contact the prescribing provider or the compounding pharmacy about disposal and replacement